(Q38298812)

1 September 2017

1 reference

title

Sequence-defined polymers for the delivery of oligonucleotides (English)

1 reference

1 September 2017

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25535686%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Ernst Wagner

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25535686%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

author name string

Taavi Lehto

series ordinal

1

1 reference

1 September 2017

Ernst Wagner

series ordinal

2

1 reference

1 September 2017

1 December 2014

1 reference

1 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25535686%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25535686%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

issue

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25535686%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

page(s)

2843-2859

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25535686%20AND%20SRC:MED&resulttype=core&format=json

The promise of microRNA replacement therapy

12 June 2020

cites work

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.166

RNA targeting therapeutics: molecular mechanisms of antisense oligonucleotides as a therapeutic platform

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.166

Targeting RNA to treat neuromuscular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.166

Silencing disease genes in the laboratory and the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.166

Cellular uptake and intracellular trafficking of antisense and siRNA oligonucleotides.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.166

RNA-based therapeutics: current progress and future prospects.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.166

Knocking down barriers: advances in siRNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.166

Peptide-mediated Cell and In Vivo Delivery of Antisense Oligonucleotides and siRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.166

Delivery materials for siRNA therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.166

Design and development of polymers for gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.166

Cell-penetrating peptides for the delivery of nucleic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.166

Cell penetrating peptide conjugates of steric block oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.166

RNA targeting with peptide conjugates of oligonucleotides, siRNA and PNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.166

Nonviral methods for siRNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.166

Different behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.166

A low molecular weight fraction of polyethylenimine (PEI) displays increased transfection efficiency of DNA and siRNA in fresh or lyophilized complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.166

Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.166

Factors affecting the clearance and biodistribution of polymeric nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.166

Pharmacokinetic consequences of pegylation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.166

Extracellular barriers to in Vivo PEI and PEGylated PEI polyplex-mediated gene delivery to the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.166

Polymers for siRNA delivery: inspired by viruses to be targeted, dynamic, and precise

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.166

Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.166

Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine-DNA complexes: toward a synthetic virus-like gene-transfer vehicle

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.166

The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.166

Solid-phase synthesis of sequence-defined T-, i-, and U-shape polymers for pDNA and siRNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.166

Direct translocation as major cellular uptake for CADY self-assembling peptide-based nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.166

Cellular uptake and intracellular trafficking of oligonucleotides: implications for oligonucleotide pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.166

Bioreducible polycations as shuttles for therapeutic nucleic acid and protein transfection.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.166

Classes and prediction of cell-penetrating peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.166

Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.166

Cell penetrating peptides: overview and applications to the delivery of oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.166

Conjugates of antisense oligonucleotides with the Tat and antennapedia cell-penetrating peptides: effects on cellular uptake, binding to target sequences, and biologic actions

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.166

HIV Tat peptide enhances cellular delivery of antisense morpholino oligomers.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.166

Vectorization of morpholino oligomers by the (R-Ahx-R)4 peptide allows efficient splicing correction in the absence of endosomolytic agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.166

Cell-penetrating peptide-morpholino conjugates alter pre-mRNA splicing of DMD (Duchenne muscular dystrophy) and inhibit murine coronavirus replication in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.166

Cell-penetrating peptide-conjugated antisense oligonucleotides restore systemic muscle and cardiac dystrophin expression and function.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.166

Sustained dystrophin expression induced by peptide-conjugated morpholino oligomers in the muscles of mdx mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.166

Morpholinos and their peptide conjugates: therapeutic promise and challenge for Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.166

A fusion peptide directs enhanced systemic dystrophin exon skipping and functional restoration in dystrophin-deficient mdx mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.166

Improved cell-penetrating peptide-PNA conjugates for splicing redirection in HeLa cells and exon skipping in mdx mouse muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.166

Pip5 transduction peptides direct high efficiency oligonucleotide-mediated dystrophin exon skipping in heart and phenotypic correction in mdx mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.166

Pip6-PMO, A New Generation of Peptide-oligonucleotide Conjugates With Improved Cardiac Exon Skipping Activity for DMD Treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.166

Cellular trafficking determines the exon skipping activity of Pip6a-PMO in mdx skeletal and cardiac muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.166

Vivo-Morpholinos: a non-peptide transporter delivers Morpholinos into a wide array of mouse tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.166

Octa-guanidine morpholino restores dystrophin expression in cardiac and skeletal muscles and ameliorates pathology in dystrophic mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.166

A novel morpholino oligomer targeting ISS-N1 improves rescue of severe spinal muscular atrophy transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.166

Targeting cyclin B1 through peptide-based delivery of siRNA prevents tumour growth

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.166

A new potent secondary amphipathic cell-penetrating peptide for siRNA delivery into mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.166

Self-assembling peptide-based nanoparticles for siRNA delivery in primary cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.166

A stearylated CPP for delivery of splice correcting oligonucleotides using a non-covalent co-incubation strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.166

Design of a peptide-based vector, PepFect6, for efficient delivery of siRNA in cell culture and systemically in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.166

PepFect 14, a novel cell-penetrating peptide for oligonucleotide delivery in solution and as solid formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.166

Delivery of nucleic acids with a stearylated (RxR)4 peptide using a non-covalent co-incubation strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.166

Targeted tumor-penetrating siRNA nanocomplexes for credentialing the ovarian cancer oncogene ID4

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.166

Tailor-made poly(amidoamine)s for controlled complexation and condensation of DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.166

Structure-activity relationships of siRNA carriers based on sequence-defined oligo (ethane amino) amides

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.166

Stabilizing effect of tyrosine trimers on pDNA and siRNA polyplexes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.166

Comb-like oligoaminoethane carriers: change in topology improves pDNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.166

Highly branched HK peptides are effective carriers of siRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.166

Small interfering RNA targeting Raf-1 inhibits tumor growth in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.166

Systemic delivery of HK Raf-1 siRNA polyplexes inhibits MDA-MB-435 xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.166

Selective modification of HK peptides enhances siRNA silencing of tumor targets in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.166

Surface-modified HK:siRNA nanoplexes with enhanced pharmacokinetics and tumor growth inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.166

Novel polymerizable surfactants with pH-sensitive amphiphilicity and cell membrane disruption for efficient siRNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.166

A peptide-targeted delivery system with pH-sensitive amphiphilic cell membrane disruption for efficient receptor-mediated siRNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.166

Targeted systemic delivery of a therapeutic siRNA with a multifunctional carrier controls tumor proliferation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.166

Cell-penetrating peptides as transporters for morpholino oligomers: effects of amino acid composition on intracellular delivery and cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.166

Functional rescue of dystrophin-deficient mdx mice by a chimeric peptide-PMO.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.14.166

21 January 2018

Identifiers

DOI

10.2217/NNM.14.166

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25535686%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

1 reference